Novo Nordisk outlays $1.09bn to boost GLP-1RA production in Brazil

Novo Nordisk has invested 6.4bn Brazilian reais ($1.09bn) to expand its facility in Brazil as the company ramps up efforts to increase production of its flagship glucagon-like peptide 1 receptor agonist (GLP-1RA) products.